Rossari BiotechNSE:ROSSARI +1.03%84 Return-on-Tangible-Equity is 16.57% as of Mar. 2026, which is 20% below its 10-year median of 20.78. GuruFocus rates NSE:ROSSARI with a GF Score™ of 84/100 and a GF Value™ of ₹1,000.03 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,567 Chemicals companies, Rossari Biotech ranks better than 81.81% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Rossari Biotech's annualized net income for the quarter that ended in Mar. 2026 was ₹1,839 Mil. Rossari Biotech's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹11,094 Mil. Therefore, Rossari Biotech's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 16.57%.
The historical rank and industry rank for Rossari Biotech's Return-on-Tangible-Equity or its related term are showing as below:
NSE:ROSSARI'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 14.56 Med: 20.78 Max: 44.59
Current: 14.59
During the past 9 years, Rossari Biotech's highest Return-on-Tangible-Equity was 44.59%. The lowest was 14.56%. And the median was 20.78%.
NSE:ROSSARI's Return-on-Tangible-Equity is ranked better than 81.81% of 1567
companies
in the Chemicals industry
Industry Median: 5.7
vs NSE:ROSSARI: 14.59
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Rossari Biotech Return-on-Tangible-Equity Related Terms
Rossari Biotech Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Rossari Biotech's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ROSSARI vs LIN, SHW, ECL: Return-on-Tangible-Equity Comparison
For the Specialty Chemicals subindustry, Rossari Biotech's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossari Biotech Return-on-Tangible-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Rossari Biotech's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Rossari Biotech's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 16.57% mean?
Rossari Biotech (NSE:ROSSARI) has a Return-on-Tangible-Equity of 16.57% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Rossari Biotech and its competitors. This is 20% below median its historical median of 20.78. Over the past decade, Rossari Biotech's Return-on-Tangible-Equity has ranged from 14.56 to 44.59. According to the industry distribution chart, Rossari Biotech ranks #285 out of 1567 companies in the Chemicals industry, placing it in the top 18.2%.
Is Rossari Biotech's Return-on-Tangible-Equity too high?
Rossari Biotech's current Return-on-Tangible-Equity of 16.57% is 20% below median its 10-year median of 20.78. Over the past 10 years, this metric has ranged from a low of 14.56 to a high of 44.59. The Chemicals industry median Return-on-Tangible-Equity is 5.70. Rossari Biotech's value of 16.57% is 190.7% above this industry median. Based on the distribution chart, Rossari Biotech ranks #285 out of 1567 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Rossari Biotech has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's Return-on-Tangible-Equity compare to LIN and SHW?
According to the Chemicals industry distribution chart, Rossari Biotech ranks #285 out of 1567 companies for Return-on-Tangible-Equity. This places Rossari Biotech in the top 18% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 5.70. Rossari Biotech's value of 16.57% is 190.7% above this benchmark. Historically, Rossari Biotech's own Return-on-Tangible-Equity has ranged from 14.56 to 44.59 over the past decade. While the company's 10-year median is 20.78 vs. the industry median of 5.70, Rossari Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Chemicals company?
The median Return-on-Tangible-Equity among Chemicals companies is 5.70, based on 1,567 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rossari Biotech's current Return-on-Tangible-Equity of 16.57% is 190.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Rossari Biotech and its competitors. For the Chemicals industry, the median Return-on-Tangible-Equity is 5.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossari Biotech's current Return-on-Tangible-Equity is 16.57%, which is 20% below median its own 10-year median of 20.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1,000.03, compared to a current price of ₹524.20 — trading 47.6% below its estimated fair value. The current Return-on-Tangible-Equity is 16.57%, which is 20% below median its 10-year median of 20.78 and 190.7% above the Chemicals industry median of 5.70. Rossari Biotech's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current Return-on-Tangible-Equity is 16.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?
Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued.
The current stock price of ₹524.20 is trading 47.6% below its estimated GF Value™ of ₹1,000.03.
GuruFocus considers Rossari Biotech to be Possible Value Trap.
Key valuation signals for NSE:ROSSARI:
Return-on-Tangible-Equity: 16.57% (20% below median its 10-year median of 20.78)
GF Value™: ₹1,000.03 vs. price of ₹524.20 (47.6% below fair value)
Industry Position: 190.7% above the Chemicals median (#285 of 1567)
No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
84GF Score
Get the complete analysis for NSE:ROSSARI
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ROSSARI has been successfully added to your 
